Drug Search Results
More Filters [+]

AG-013726

Alternative Names: ag-013726, ag013726, ag 013726
Latest Update: 2013-12-06
Latest Update Note: Clinical Trial Update

Product Description

For metastatic colorectal cancer (Sourced from: https://clinicaltrials.gov/ct2/show/NCT00460603)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Pfizer
Company Location: NEW YORK NY 10017
Company CEO: Albert Bourla
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for AG-013726

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title